Publications by authors named "Nicolas Touchot"

Claim this Profile
E
Economics of hypothalamic obesity in patients with craniopharyngioma and other rare sellar/suprasellar tumors.
Julian Witte, Nicolas Touchot, Bastian Surmann, Kylie Braegelmann, Mathias Flume

Eur J Health Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of acquired hypothalamic obesity following traumatic brain injury and nonspecific hypothalamic microinjury: A nationwide German claims data analysis.
Julian Witte, Nicolas Touchot, Manuel Batram, Jana Diekmannshemke, Mathias Flume

J Neuroendocrinol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-Onset of Obesity Model: Impact of Early-Onset Obesity on Comorbidity Risk and Life Expectancy.
Urs C H Wiedemann, Erica L T van den Akker, Thomas M Barber, Karine Clément, Sadaf Farooqi, Nicolas Touchot

Obes Facts· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome.
Andrea M Haqq, Christine Poitou, Wendy K Chung, Elizabeth Forsythe, Rushika Conroy, Nicolas Touchot

J Clin Endocrinol Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with tumor/treatment-related hypothalamic obesity in the first two years following surgical treatment or radiotherapy.
Hermann L Müller, Julian Witte, Bastian Surmann, Manuel Batram, Kylie Braegelmann, Nicolas Touchot

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors-A German claims database analysis.
Julian Witte, Bastian Surmann, Manuel Batram, Markus Weinert, Mathias Flume, Nicolas Touchot

J Neuroendocrinol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to manage 'affordability' of high budget impact medicines in key EU countries.
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Nicolas Touchot

J Mark Access Health Policy· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Insights from Commercialization of Gene Therapies in Europe.
Nicolas Touchot, Mathias Flume

Genes (Basel)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and attractiveness of indication value-based pricing in key EU countries.
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Nicolas Touchot

J Mark Access Health Policy· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The payers' perspective on gene therapies.
Nicolas Touchot, Mathias Flume

Nat Biotechnol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis